Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda.

BMC infectious diseases - 19 Dec 2014

Ezati Nicholas, Lukoye Deus, Wampande Eddie M, Musisi Kenneth, Kasule George W, Cobelens Frank G J, Kateete David P, Joloba Moses L

Abstract excerpt

BACKGROUND: The global increase in the burden of multidrug-resistant tuberculosis (MDR-TB) underscores an urgent need for data on factors involved in generation and spread of TB drug resistance. We performed molecular analyses on a representative sample of Mycobacterium tuberculosis (MTB) isolate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Coinfection
Share to Drug Resistance, Multiple, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Epidemiology

Share to Mycobacterium tuberculosis

Share to Tuberculosis

Share to Tuberculosis, Multidrug-Resistant

Share to Uganda

Source

Open in PubMed Open full text

Identifiers

PMID: 25523472
DOI: 10.1186/s12879-014-0703-0
PMCID: PMC4367914

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25523472-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda.PMID 25523472Read ↗

Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families.Semantic proximity Read ↗

Comparative genomic analysis of <i>Mycobacterium tuberculosis</i> reveals evolution and genomic instability within Uganda I sub-lineageSemantic proximity Read ↗

Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda.Semantic proximity Read ↗

Patient Single Nucleotide Polymorphisms associated with Mycobacterium tuberculosis genotypes in the Ugandan populationSemantic proximity Read ↗

Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in South-Western Uganda.Semantic proximity Read ↗

Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda.Semantic proximity Read ↗

Mycobacterium tuberculosis Uganda genotype is the predominant cause of TB in Kampala, Uganda.Semantic proximity Read ↗

Long-term dominance of Mycobacterium tuberculosis Uganda family in peri-urban Kampala-Uganda is not associated with cavitary disease.Semantic proximity Read ↗

Molecular investigation of multiple strain infections in patients with tuberculosis in Mubende district, Uganda.Semantic proximity Read ↗

Resistance to TST/IGRA conversion in Uganda: Heritability and Genome-Wide Association Study.Semantic proximity Read ↗

Distribution and transmission of Mycobacterium tuberculosis complex lineages among children in peri-urban Kampala, Uganda.Semantic proximity Read ↗

<i>Phylogenetic population structure</i> and drug resistance <i>of Mycobacterium tuberculosis complex in the Volta Region of Ghana</i>Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.